RankingsPricing
  1. JP-listed companies
  2. StemCell Institute Inc.
  3. Financials
  4. Total current assets

StemCell Institute Inc.JP:7096

Market cap
¥8.1B
P/E ratio
25.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 20255,172+14.56%
Mar 31, 20244,515-0.67%
Mar 31, 20234,545+8.79%
Mar 31, 20224,178+32.63%
Mar 31, 20213,150-5.91%
Mar 31, 20203,348+25.13%
Mar 31, 20192,676

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)